The global fecal pancreatic elastase testing market was valued at USD 17,504.0 million in 2025 and is projected to be elevated to USD 36,413.3 million by 2035, registering a CAGR of 7.6% over the forecast period. Growth has been driven by the increasing incidence of exocrine pancreatic insufficiency and the rising preference for non-invasive stool-based …